PRDX2, peroxiredoxin 2, 7001

N. diseases: 243; N. variants: 2
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
CUI: C0005129
Disease: Bernard-Soulier Syndrome
Bernard-Soulier Syndrome
0.030 GeneticVariation disease BEFREE Geometries of platelets in citrated PRP obtained from normal donors (17) and donors (5) with a hereditary dominant giant platelet syndrome, herein referred to as "Montreal platelet syndrome" (MPS), are compared. 759524 1979
CUI: C0398642
Disease: Montreal platelet syndrome
Montreal platelet syndrome
0.020 Biomarker disease BEFREE Geometries of platelets in citrated PRP obtained from normal donors (17) and donors (5) with a hereditary dominant giant platelet syndrome, herein referred to as "Montreal platelet syndrome" (MPS), are compared. 759524 1979
CUI: C0005129
Disease: Bernard-Soulier Syndrome
Bernard-Soulier Syndrome
0.030 Biomarker disease BEFREE Platelet size on blood smear is compared with platelet size and shape in suspension (i.e., whole blood and citrated platelet-rich plasma [PRP]) for normal donors and 16 patients with hereditary "giant" platelet syndromes (HGPS), including Bernard-Soulier syndrome (BSS) (seven patients), Montreal platelet syndrome (MPS) (three patients), May-Hegglin anomaly (one patient) and Rafael platelet defect (one patient). 4031633 1985
CUI: C0398642
Disease: Montreal platelet syndrome
Montreal platelet syndrome
0.020 Biomarker disease BEFREE In this manner it was shown that for all donors with BSS and MPS, the shape-changed platelets are disproportionately larger than the D. In contrast, in the remaining patients with HGPS the size of the shape-changed platelets was consistent with the size predicted from the D. Examination of VT for MPS as a function of time after addition of 10 mumol/L adenosine diphosphate to PRP revealed an abnormal time course, thereby pointing to an abnormality in the mechanisms that regulate platelet size during shape change. 4031633 1985
CUI: C0340978
Disease: May-Hegglin anomaly
May-Hegglin anomaly
0.010 GeneticVariation phenotype BEFREE Platelet size on blood smear is compared with platelet size and shape in suspension (i.e., whole blood and citrated platelet-rich plasma [PRP]) for normal donors and 16 patients with hereditary "giant" platelet syndromes (HGPS), including Bernard-Soulier syndrome (BSS) (seven patients), Montreal platelet syndrome (MPS) (three patients), May-Hegglin anomaly (one patient) and Rafael platelet defect (one patient). 4031633 1985
CUI: C1854520
Disease: SEBASTIAN SYNDROME
SEBASTIAN SYNDROME
0.010 GeneticVariation disease BEFREE Platelet size on blood smear is compared with platelet size and shape in suspension (i.e., whole blood and citrated platelet-rich plasma [PRP]) for normal donors and 16 patients with hereditary "giant" platelet syndromes (HGPS), including Bernard-Soulier syndrome (BSS) (seven patients), Montreal platelet syndrome (MPS) (three patients), May-Hegglin anomaly (one patient) and Rafael platelet defect (one patient). 4031633 1985
CUI: C0162534
Disease: Prion Diseases
Prion Diseases
0.100 GeneticVariation group BEFREE These studies argue that amino acid substitutions in 'PrP' genes may modulate initiation and development of prion diseases. 2473558 1989
Gerstmann-Straussler-Scheinker Disease
0.070 GeneticVariation disease BEFREE Discovery of a point mutation in the Prp gene from humans with GSS established that GSS is unique among human diseases--it is both genetic and infectious. 1684745 1991
CUI: C0751254
Disease: Creutzfeldt-Jakob Disease, Familial
Creutzfeldt-Jakob Disease, Familial
0.010 GeneticVariation disease BEFREE A PrP gene codon 178 base substitution and a 24-bp interstitial deletion in familial Creutzfeldt-Jakob disease. 1357594 1992
CUI: C0162534
Disease: Prion Diseases
Prion Diseases
0.100 GeneticVariation group BEFREE Growth factors like NGF are known to increase the expression of PrP gene, a housekeeping gene which is responsible for susceptibility to transmissible spongiform encephalopathies. 7902706 1993
CUI: C0085584
Disease: Encephalopathies
Encephalopathies
0.020 Biomarker group BEFREE PrP gene and its association with spongiform encephalopathies. 8137132 1993
CUI: C0022336
Disease: Creutzfeldt-Jakob disease
Creutzfeldt-Jakob disease
0.100 GeneticVariation disease BEFREE Furthermore, the linkage of mutations within the PRNP gene with phenotypic appearance of Creutzfeldt-Jakob disease and Gerstmann-Sträussler-Scheinker syndrome points to importance of the PrP gene. 7922109 1994
CUI: C0022336
Disease: Creutzfeldt-Jakob disease
Creutzfeldt-Jakob disease
0.100 GeneticVariation disease BEFREE The epidemiological data suggests a very high familial incidence of CJD in this population and a molecular genetic research elucidated that CJD segregates with a point mutation at codon 200 of the PrP gene resulting in the substitution of Lysine for Glutamate. 7858176 1994
CUI: C0162534
Disease: Prion Diseases
Prion Diseases
0.100 GeneticVariation group BEFREE The identification of pathogenic PrP alleles and the role of the codon 129 PrP gene polymorphism in determining susceptibility to prion disease provides strong support for the idea that an abnormal isoform of PrP, PrPSc, is the principal constituent of the prion and that its propagation involves direct PrP-PrP interactions which occur most readily between identical PrP molecules. 7913754 1994
Gerstmann-Straussler-Scheinker Disease
0.070 GeneticVariation disease BEFREE Furthermore, the linkage of mutations within the PRNP gene with phenotypic appearance of Creutzfeldt-Jakob disease and Gerstmann-Sträussler-Scheinker syndrome points to importance of the PrP gene. 7922109 1994
Gerstmann-Straussler-Scheinker Disease
0.070 GeneticVariation disease BEFREE The discovery of mutations in the PrP gene which segregates with other familial prion diseases such as Gerstmann-Straussler syndrome (GSS) lead us to perform a molecular genetic study and compare it to an epidemiological survey among the Libyan community. 7858176 1994
CUI: C0162534
Disease: Prion Diseases
Prion Diseases
0.100 Biomarker group BEFREE The pathogenic PrP protein accumulating in the brain of TSE patients is a protease-resistant and insoluble product of a precursor protein molecule of unknown function that is encoded by the PRNP gene on chromosome 20. 7598484 1995
CUI: C0085584
Disease: Encephalopathies
Encephalopathies
0.020 Biomarker group BEFREE New advances in immunoassays and PrP gene analysis now provide important adjuncts in recognizing the spectrum of disorders of PrP metabolism associated with these transmissible encephalopathies. 7767489 1995
CUI: C0022336
Disease: Creutzfeldt-Jakob disease
Creutzfeldt-Jakob disease
0.100 GeneticVariation disease BEFREE FFI and a familial type of Creutzfeldt-Jakob disease (CJD178), share the D178N mutation in the PrP gene but have distinct phenotypes linked to codon 129, the site of a methionine/valine polymorphism (129M/V). 8647879 1996
CUI: C0022336
Disease: Creutzfeldt-Jakob disease
Creutzfeldt-Jakob disease
0.100 Biomarker disease BEFREE Sequencing of the patient's Prp gene did not reveal the abnormalities expected in a familial case of CJD. 8978943 1996
CUI: C0162534
Disease: Prion Diseases
Prion Diseases
0.100 Biomarker group BEFREE There were no mutations found in the Prp gene, so it is possible that there are SEs caused by genes or other pathological processes unrelated to the Prp gene. 8978943 1996
CUI: C0162534
Disease: Prion Diseases
Prion Diseases
0.100 Biomarker group BEFREE Age at disease onset and rate of progression of transmissible spongiform encephalopathies in man, sheep and mice are modulated by the host genome, in particular by the PrP gene and its allelic forms. 8922485 1996
CUI: C4281802
Disease: Spongiform encephalopathy
Spongiform encephalopathy
0.010 Biomarker disease BEFREE There were no mutations found in the Prp gene, so it is possible that there are SEs caused by genes or other pathological processes unrelated to the Prp gene. 8978943 1996
CUI: C0162534
Disease: Prion Diseases
Prion Diseases
0.100 Biomarker group BEFREE A number of lines of biochemical evidence implicate the disease-specific isoform, PrPsc, as the transmissible agent and genetic analysis has shown tight linkage between PrP gene mutations and polymorphisms and differential susceptibility to prion diseases, Perhaps the strongest evidence for a protein-only model of the agent is that PrP gene-ablated mice are resistant to scrapie and that mice with PrP mutation, corresponding to those found in a human familial prion disease, spontaneously develop a transmissible prion disease. 9239743 1997
CUI: C0162534
Disease: Prion Diseases
Prion Diseases
0.100 GeneticVariation group BEFREE Polymorphisms in the PrP gene are linked to differences in susceptibility for prion diseases. 9144167 1997